Multicenter Trial Oversight

Multicenter Trial Oversight is a formal governance mechanism within research ethics oversight that coordinates and harmonizes ethical review processes across multiple institutional review boards or ethics committees involved in a single multisite clinical trial to ensure consistent application of ethical standards, regulatory compliance, and participant protection.

17

Publications

869

Citations

81

Authors

44

Institutions

Publications per year

2017–2026

2

Authors

81

  1. CL
    Curtis L. Meinert

    Johns Hopkins University, United States

    2 publications · 35 citations

    2

    h-index

  2. KB
    K. Brandon Strenge

    The Orthopaedic Institute, United States

    1 publications · 15 citations

    1

    h-index

  3. RV
    Russell V. Luepker

    University of Minnesota, United States

    1 publications · 68 citations

    1

    h-index

  4. RD
    Rafael Dal−Ré

    GlaxoSmithKline (Spain), Spain

    1 publications · 13 citations

    1

    h-index

  5. SI
    Shrikant I. Bangdiwala

    University of North Carolina at Chapel Hill, United States

    1 publications · 27 citations

    1

    h-index

1–5 of 81

Venues

  1. Controlled Clinical Trials

    2 publications · 38 citations

    2

    h-index

  2. New England Journal of Medicine

    NEJM · 2 publications · 327 citations

    2

    h-index

  3. IRB Ethics and Human Research

    2 publications · 29 citations

    2

    h-index

  4. Preventive Medicine

    PM · 1 publications · 68 citations

    1

    h-index

  5. Annals of Internal Medicine

    1 publications · 153 citations

    1

    h-index

1–5